期刊文献+

哌拉西林/他唑巴坦在急性弥漫性腹膜炎围手术期的应用

Piperacillin/tazobactam for acute diffuse peritonitis during perioperative period
原文传递
导出
摘要 目的探讨急性弥漫性腹膜炎抗菌药物治疗方法。方法回顾性分析2011年2月-2011年7月医院普外科行手术治疗的急性弥漫性腹膜炎36例,术中常规行腹腔脓液细菌培养及药敏试验,围手术期应用哌拉西林/他唑巴坦及甲硝唑联合抗感染。结果所有患者皆临床治愈;住院时间5~25d,平均13.5d;88.9%的病原菌对哌拉西林/他唑巴坦敏感,所有病例无腹腔残余脓肿发生。结论哌拉西林/他唑巴坦在急性弥漫性腹膜炎经验性抗菌药物治疗中安全、有效。 OBJECTIVE To investigate the use of antibiotics for treatment of acute diffuse peritonitis.METHODS The data of 36 patients with acute diffuse peritonitis who underwent surgical operation from Feb 2011 to Jul 2011 were analyzed retrospectively.Germ culture for purulence derived from abdominal cavity and drug susceptibility testing was performed during the operation,and piperacillin/tazobactam(4:1)plus metronidazole were used for anti-infection therapy during perioperative period.RESULTS All the patients were cured;the duration of hospital stay ranged from 5 days to 25 days,with 13.5 days in average;88.89% of the pathogens were proved susceptible to piperacillin/tazobactam,there was no case with residual intraperitoneal abscess.CONCLUSION Piperacillin/tazobactam is effective and safe in experiential treatment of acute diffuse peritonitis during the perioperative period.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2012年第14期3151-3152,3155,共3页 Chinese Journal of Nosocomiology
关键词 急性弥漫性腹膜炎 抗菌药物 治疗 Acute diffuse peritonitis Antibiotics Treatment
  • 相关文献

参考文献9

  • 1Montravers P, Chalfine A, Gauzit R, et al. Clinical and ther- apeutic features of nonpostoperative nosocomial intra-abdomi- hal infection[J].Ann Surg,2004,239(3) 409 416.
  • 2Marshall JC. Intra abdominal infections[J]. Mic Infect,2004, 6(11) : 1015-1025.
  • 3Gauzit R, Pean Y, Barth X, et al. Epidemiology, manage ment,and prognosis of secondary non-postoperative peritoni tis:A french prospective observational multicenter study[J].Surg Infect (Larchmt), 2009,10(2) : 119-127.
  • 4Krobot K, Yin D, Zhang Q, et al. Effect of inappropriate ini tial empiric antibiotic therapy on outcome of patients withcommunity-acquired intra-abdominal infections requiring sur geryEJ. Eur J Clin Microbiol Infect Dis,2004,23(9):682- 687.
  • 5Wong PF, Gilliam AD, Kumar S, et al. Antibiotic regimens for secondary peritonitis of gastrointestinal origin in adults [M]. John Wiley Sons Ltd, 2005:4.
  • 6Solomkin JS, Mazuski JE, baron Ej, et al. Guidelines for the selection of anti-infective agents for complicated intra-abdomi- nal infections[J]. Clin Infect Dis, 200a, 37 (8) : 997-1005.
  • 7张瑞琴,张谨宇,张润梅,徐辉.2004-2006年医院感染菌群及耐药性变化趋势分析[J].中华医院感染学杂志,2008,18(10):1437-1440. 被引量:30
  • 8Wang FD, Lin ML, Lee WS, etal. In vitro activities of beta lactam an-tibiotics alone and in combination with sulbactam a gainst Gram-negative bacteria[J]. Int J Antimicrob Agents 2004,23 (6) : 590-595.
  • 9谢俊平,高德义.哌拉西林/他唑巴坦治疗肝硬化并自发性细菌性腹膜炎的成本效果分析[J].中华医院感染学杂志,2011,21(6):1211-1213. 被引量:12

二级参考文献9

共引文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部